Human papillomavirus: Changing paradigms in oropharyngeal cancer

Current Oncology Reports

Volumn 12, Issue 2, 2010, Pages 115-120

  Adelstein, David J ^a   Rodriguez, Cristina P ^a  

^a TAUSSIG CANCER INSTITUTE   (United States)

Author keywords

Head and neck cancer; Human papillomavirus; Oropharynx cancer

Indexed keywords

CISPLATIN; WART VIRUS VACCINE;

CANCER ADJUVANT THERAPY; CANCER PREVENTION; CANCER SURVIVAL; CAUCASIAN; CLINICAL EFFECTIVENESS; CLINICAL TRIAL; COLORECTAL CANCER; DISEASE ASSOCIATION; EVIDENCE BASED PRACTICE; HUMAN; INTERMETHOD COMPARISON; OROPHARYNX CANCER; PAPILLOMAVIRUS INFECTION; PROGNOSIS; REVIEW; RISK REDUCTION; SEX DIFFERENCE; SMOKING CESSATION; SQUAMOUS CELL CARCINOMA; TOBACCO DEPENDENCE; TREATMENT RESPONSE; VIRUS CARCINOGENESIS; WART VIRUS;

CARCINOMA, SQUAMOUS CELL; CLINICAL TRIALS AS TOPIC; HUMANS; OROPHARYNGEAL NEOPLASMS; PAPILLOMAVIRIDAE; PAPILLOMAVIRUS INFECTIONS; SURVIVAL RATE;

EID: 77952237143     PISSN: 15233790     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11912-010-0084-5     Document Type: Review

References (34)

1. D'Souza G, Gillison ML: Head and neck squamous cell cancers in the nonsmoker-nondrinker. In Current Clinical Oncology: Squamous Cell Head and Neck Cancer. Edited by Adelstein DJ. Totowa, NJ: Humana Press; 2005:1-26.
2. ML Gillison 2007 Current topics in the epidemiology of oral cavity and oropharyngeal cancers Head Neck 29 779 792 10.1002/hed.20573 17230556 (Pubitemid 47265534)
3. •• Adelstein DJ, Ridge JA, Gillison ML, et al.: Head and neck squamous cell cancer and the human papillomavirus: summary of a National Cancer Institute State of the Science Meeting, November 9-10, 2008, Washington, DC. Head Neck 2009, 31:1393-1422. This article provides a comprehensive summary of the epidemiology, basic science, and clinical implications of HPV-associated head and neck cancer.
4. AK Chaturvedi EA Engels WF Anderson ML Gillison 2008 Incidence trends for human papillomavirus-related and -unrelated oral squamous cell carcinoma in the United States J Clin Oncol 26 612 619 10.1200/JCO.2007.14.1713 18235120 (Pubitemid 351264356)
5. L Licitra G Zigon G Gatta, et al. 2008 Human papillomavirus in HNSCC: a European epidemiologic perspective Hematol Oncol Clin N Am 22 1143 1153 10.1016/j.hoc.2008.10.002
6. AR Kreimer GM Clifford P Boyle S Franceschi 2005 Human papillomavirus types in head and neck squamous cell carcinomas worldwide: a systemic review Cancer Epidemiol Biomarkers Prev 14 467 475 10.1158/1055-9965.EPI-04-0551 1:CAS:528:DC%2BD2MXhs1GhsLg%3D 15734974 (Pubitemid 40270113)
7. DM Parkin F Bray 2006 Chapter 2: the burden of HPV-related cancers Vaccine 24 S11 S25 10.1016/j.vaccine.2006.05.111 (Pubitemid 44404053)
8. C Fahkry WH Westra S Li, et al. 2008 Improved survival of patients with human papillomavirus-positive head and neck squamous cell carcinoma in a prospective clinical trial J Natl Cancer Inst 100 261 269 10.1093/jnci/djn011 This article reports on the first cooperative group clinical trial to prospectively demonstrate the prognostic importance of HPV positivity on response and survival after chemoradiotherapy. (Pubitemid 351480538)
9. L Hammarstedt D Lindquist H Dahlstrand, et al. 2006 Human papillomavirus as a risk factor for the increase in incidence of tonsillar cancer Int J Cancer 119 2620 2623 10.1002/ijc.22177 1:CAS:528:DC%2BD28XhtFygur7N 16991119 (Pubitemid 44691317)
10. EM Smith JM Ritchie KF Summersgill, et al. 2004 Age, sexual behavior, and human papillomavirus infection in oral cavity and oropharyngeal cancers Int J Cancer 108 766 772 10.1002/ijc.11633 1:CAS:528:DC%2BD2cXmvFWltg%3D%3D 14696105 (Pubitemid 38076410)
11. G D'Souza AR Kreimer R Viscidi, et al. 2007 Case-control study of human papillomavirus and oropharyngeal cancer N Engl J Med 356 1944 1956 10.1056/NEJMoa065497 17494927 This study provides strong support for the association of oropharyngeal cancer, oral HPV infection and high risk sexual behavior. (Pubitemid 46740304)
12. RI Haddad DM Shin 2008 Recent advances in head and neck cancer N Engl J Med 359 1143 1154 10.1056/NEJMra0707975 1:CAS:528:DC%2BD1cXhtFWrsLvI 18784104
13. C Fahkry ML Gillison 2006 Clinical implications of human papillomavirus in head and neck cancers J Clin Oncol 24 2606 2611 10.1200/JCO.2006.06.1291 (Pubitemid 46622080)
14. PM Weinberger Z Yu BG Haffty, et al. 2006 Molecular classification identifies a subset of human papillomavirus-associated oropharyngeal cancers with favorable prognosis J Clin Oncol 24 736 747 10.1200/JCO.2004.00.3335 1:CAS:528:DC%2BD28XitVGisLc%3D 16401683 (Pubitemid 46622040)
15. B Kumar KG Cordell JS Lee, et al. 2008 EGFR, p16, HPV Titer, Bcl-xL and p53, sex, and smoking as indicators of response to therapy and survival in oropharyngeal cancer J Clin Oncol 26 3128 3137 10.1200/JCO.2007.12.7662 18474878
16. CS Kong B Narasimhan H Cao, et al. 2009 The relationship between human papillomavirus status and other molecular prognostic markers in head and neck squamous cell carcinomas Int J Radiation Oncology Biol Phys 74 553 561 1:CAS:528:DC%2BD1MXls1ynt7g%3D
17. N Reimers HU Kasper SJ Weissenborn, et al. 2007 Combined analysis of HPV-DNA, p16 and EGFR expression to predict prognosis in oropharyngeal cancer Int J Cancer 120 1731 1738 10.1002/ijc.22355 1:CAS:528:DC%2BD2sXjtFOktL0%3D 17236202 (Pubitemid 46399359)
18. PM Weinberger Z Yu P Kountourakis, et al. 2009 Defining molecular phenotypes of human papillomavirus-associated oropharyngeal squamous cell carcinoma: validation of three-class hypothesis Otolaryngol-Head Neck Surg 141 382 389 10.1016/j.otohns.2009.04.014 19716018
19. S Begum WH Westra 2008 Basaloid squamous cell carcinoma of the head and neck is a mixed variant that can be further resolved by HPV status Am J Surg Pathol 32 1044 1050 10.1097/PAS.0b013e31816380ec 18496144
20. S Begum D Cao M Gillison, et al. 2005 Tissue distribution of human papillomavirus 16 DNA integration in patients with tonsillar carcinoma Clin Cancer Res 11 5694 5699 10.1158/1078-0432.CCR-05-0587 1:CAS:528: DC%2BD2MXos1CjsLw%3D 16115905 (Pubitemid 41170292)
21. A Psyrri P Gouveris JB Vermorken 2009 Human papillomavirus-related head and neck tumors: Clinical and research implication Curr Opin Oncol 21 201 205 10.1097/CCO.0b013e328329ab64 19370803
22. L Licitra F Perrone P Bossi, et al. 2006 High-risk human papillomavirus affects prognosis in patients with surgically treated oropharyngeal squamous cell carcinoma J Clin Oncol 24 5630 5636 10.1200/JCO.2005.04.6136 1:CAS:528:DC%2BD2sXhtVChsr0%3D 17179101 (Pubitemid 46631302)
23. CCR Ragin E Taioli 2007 Survival of squamous cell carcinoma of the head and neck in relation to human papillomavirus infection: Review and meta-analysis Int J Cancer 121 1813 1820 10.1002/ijc.22851 1:CAS:528:DC%2BD2sXhtVyktb7E 17546592 This article provides a meta-analysis of retrospective studies assessing the prognostic importance of HPV in head and neck squamous cell cancer. (Pubitemid 47417302)
24. FP Worden B Kumar JS Lee, et al. 2008 Chemoselection as a strategy for organ preservation in advanced oropharynx cancer: response and survival positively associated with HPV16 copy number J Clin Oncol 26 3138 3146 10.1200/JCO.2007.12.7597 1:CAS:528:DC%2BD1cXptlKgtL4%3D 18474879 This article reports on a second, smaller prospective trial confirming the favorable prognosis of HPV-positive cancers after chemoradiotherapy.
25. INK4A expression on response to radiotherapy and survival in squamous cell carcinoma of the head and neck J Clin Oncol 27 1992 1998 10.1200/JCO.2008.20.2853 1:CAS:528:DC%2BD1MXls1CgtLo%3D 19289615
26. ML Gillison J Harris W Westra, et al. 2009 Survival outcomes by tumor human papillomavirus status in stage III-IV oropharyngeal cancer in RTOG 0129 [abstract 6003] J Clin Oncol 27 7s 10.1200/JCO.2009.23.2439
27. HC Hafkamp JJ Manni A Haesevoets, et al. 2008 Marked differences in survival rate between smokers and nonsmokers with HPV 16-associated tonsillar carcinomas Int J Cancer 122 2656 2664 10.1002/ijc.23458 1:CAS:528: DC%2BD1cXht1eku73I 18360824 (Pubitemid 351631366)
28. JP Pignon A le Maitre E Maillard J Bourhis 2009 Meta-analysis of chemotherapy in head and neck cancer (MACH-NC): an update on 93 randomised trials and 17, 346 patients Radiother Oncol 92 4 14 10.1016/j.radonc.2009.04.014 19446902
29. F Denis P Garaud E Bardet, et al. 2004 Final results of the 94-01 French Head and Neck Oncology and Radiotherapy Group randomized trial comparing radiotherapy alone with concomitant radiochemotherapy in advanced-stage oropharynx carcinoma J Clin Oncol 22 69 76 10.1200/JCO.2004.08.021 14657228 (Pubitemid 41095116)
30. MA List J Stracks L Colangelo, et al. 2000 How do head and neck cancer patients prioritize treatment outcomes before initiating treatment? J Clin Oncol 18 877 884 1:STN:280:DC%2BD3c7jvFCqtg%3D%3D 10673531 (Pubitemid 30106620)
31. The Future II Study Group 2007 Quadrivalent vaccine against human papillomavirus to prevent high-grade cervical lesions N Engl J Med 356 1915 1927 10.1056/NEJMoa061741 These two articles [31••, 32••] report on the two studies that established the utility of the quadrivalent HPV vaccine in reducing the incidence of high-grade cervical intraepithelial neoplasia. (Pubitemid 46740302)
32. SM Garland M Hernandez-Avila CM Wheeler, et al. 2007 Quadrivalent vaccine against human papillomavirus to prevent anogenital diseases N Engl J Med 356 1928 1943 10.1056/NEJMoa061760 1:CAS:528:DC%2BD2sXltFSmtLo%3D 17494926 These two articles [31••, 32••] report on the two studies that established the utility of the quadrivalent HPV vaccine in reducing the incidence of high-grade cervical intraepithelial neoplasia (Pubitemid 46740303)
33. ML Gillison AK Chaturvedi DR Lowy 2008 HPV Prophylactic vaccines and the potential prevention of noncervical cancers in both men and women Cancer 113 3036 3046 18980286
34. AR Giuliano D Salmon 2008 The case for a gender-neutral (universal) human papillomavirus vaccination policy in the United States: point Cancer Epidemiol Biomarkers Prev 17 805 808 10.1158/1055-9965.EPI-07-0741 18398020 (Pubitemid 351536409)